Health Care & Life Sciences » Pharmaceuticals | Nuvo Pharmaceuticals Inc.

Nuvo Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
18,409.00
13,057.00
20,495.00
27,039.00
17,523.00
19,998
Cost of Goods Sold (COGS) incl. D&A
5,858.00
6,000.00
9,838.00
11,385.00
8,122.00
10,702
Gross Income
12,551.00
7,057.00
10,657.00
15,654.00
9,401.00
9,296
SG&A Expense
16,054.00
20,566.00
3,843.00
8,066.00
7,615.00
9,463
EBIT
3,503.00
13,509.00
-
7,588.00
1,786.00
167
Unusual Expense
6,358.00
50,679.00
-
-
25.00
6,634
Non Operating Income/Expense
171.00
1,953.00
1,006.00
323.00
336.00
429
Interest Expense
649.00
713.00
1.00
1.00
-
-
Pretax Income
10,261.00
38,609.00
8,335.00
7,409.00
1,582.00
6,340
Income Tax
117.00
19.00
7.00
-
1.00
187
Consolidated Net Income
10,378.00
38,590.00
8,328.00
7,409.00
1,581.00
6,153
Net Income
10,378.00
38,590.00
8,328.00
7,409.00
1,581.00
6,153
Net Income After Extraordinaries
10,378.00
38,590.00
23,776.00
10,589.00
1,581.00
6,153
Net Income Available to Common
10,378.00
38,590.00
7,120.00
4,229.00
1,581.00
6,153
EPS (Basic)
1.18
3.85
0.65
0.37
0.14
0.54
Basic Shares Outstanding
8,808.00
10,023.00
10,926.00
11,455.00
11,550.00
11,443
EPS (Diluted)
1.18
3.76
0.65
0.36
0.12
0.54
Diluted Shares Outstanding
8,808.00
10,269.00
10,926.00
11,711.00
11,723.00
11,443
EBITDA
2,165.00
12,794.00
7,090.00
7,813.00
2,044.00
2,326
Non-Operating Interest Income
78.00
199.00
516.00
145.00
157.00
32

About Nuvo Pharmaceuticals

View Profile
Address
6733 Mississauga Road
Mississauga Ontario L5N 6J5
Canada
Employees -
Website http://www.nuvopharmaceuticals.com
Updated 07/08/2019
Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through two business units: Topical Products and Technology Group and the Immunology Group. The Topical Products and Technology Group business unit has four U.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.